Paola Frati

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b

Elisabetta Vergani, Lorenza Di Guardo, Matteo Dugo et al. · Oncotarget · 2015 · 102 citations · Full text

Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I–Modified Peptides

Paola Filipazzi, Lorenzo Pilla, Luigi Mariani et al. · Clinical Cancer Research · 2012 · 70 citations

Neuroanatomy and cadaver dissection in Italy: history, medicolegal issues, and neurosurgical perspectives

Paola Frati, Alessandro Frati, Maurizio Salvati et al. · Journal of neurosurgery · 2006 · 42 citations

Neurosurgical Perspectives, Interdisciplinary Neurosurgery, Italian Anatomical Tradition +23

Transcriptional Profiling of Melanoma Sentinel Nodes Identify Patients with Poor Outcome and Reveal an Association of CD30+ T Lymphocytes with Progression

Viviana Vallacchi, Elisabetta Vergani, Chiara Camisaschi et al. · Cancer Research · 2014 · 35 citations

Transcriptional Profiling, Cd30+ T, Poor Outcome +17

The Critical Role of the Clinical Research Coordinator for Clinical Trials: A Survey in Oncology

M. Cinefra, Celeste Cagnazzo, Laura McMahon et al. · Medicine Access Point of Care · 2017 · 17 citations · Full text

Clinical Research Coordinator, Cancer Management, Evidence-based Medicine +19